U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2427124271Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected AdultsActive, not recruitingNo Results AvailableHIV-1 InfectionDrug: STB|Drug: TVD|Drug: ATR|Drug: RTV|Drug: ATV|Drug: ABC/3TC|Drug: Iohexolhttps://ClinicalTrials.gov/show/NCT02246998
2427224272Bioavailability of Carotenoids Added Into Processed FoodsRecruitingNo Results AvailableCardiovascular DiseaseDietary Supplement: Control|Dietary Supplement: Vegetable bread only|Dietary Supplement: Plain bread with vegetable mayonnaise|Dietary Supplement: Vegetable bread with plain mayonnaisehttps://ClinicalTrials.gov/show/NCT02246985
2427324273BraveMind: Advancing the Virtual Iraq/Afghanistan PTSD Exposure TherapyRecruitingNo Results AvailableTrauma|Post-Traumatic Stress DisorderBehavioral: Virtual Reality Exposure Therapy (VRET)https://ClinicalTrials.gov/show/NCT02246972
2427424274Process Versus Outcomes Incentives for Lipid ManagementEnrolling by invitationNo Results AvailableDiabetes|Cardiovascular DiseaseBehavioral: Process Incentive|Behavioral: Outcome Incentivehttps://ClinicalTrials.gov/show/NCT02246959
2427524275Positive Airway Pressure on Pleural Effusion After DrainageRecruitingNo Results AvailablePleural EffusionDevice: Positive Airway Pressure|Other: Conventional Chest Physiotherapy|Procedure: Control grouphttps://ClinicalTrials.gov/show/NCT02246946
2427624276Effects of a PUFA-rich Diet on Acute Metabolic and Inflammatory High-Fat Meal ResponsesRecruitingNo Results AvailableInflammation|ObesityOther: PUFA Diet|Other: Control Diethttps://ClinicalTrials.gov/show/NCT02246933
2427724277Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis PatientsCompletedNo Results AvailableSeasonal Allergic RhinitisDrug: Fluticasone propionate|Drug: Flonase®|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02246920
2427824278Exercise and Quality of Life in Leukemia PatientsRecruitingNo Results AvailableAcute LeukemiaOther: Exercisehttps://ClinicalTrials.gov/show/NCT02246907
2427924279A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.CompletedNo Results AvailableHaemophilia ABiological: Optivate® (Human Coagulation Factor VIII)https://ClinicalTrials.gov/show/NCT02246894
2428024280A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.CompletedNo Results AvailableVon Willebrand DiseaseBiological: Optivate® (Human Coagulation Factor VIII)https://ClinicalTrials.gov/show/NCT02246881
2428124281An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.CompletedNo Results AvailableHaemophilia ABiological: Optivate® (Human Coagulation Factor VIII)https://ClinicalTrials.gov/show/NCT02246868
2428224282A Comparison of the Pharmacokinetics, Safety and Tolerance of Two Formulations of a Liquid IVIg in Healthy VolunteersCompletedNo Results AvailableHealthyBiological: Gammaplex® (Human Normal Immunoglobulin)https://ClinicalTrials.gov/show/NCT02246855
2428324283A Study Comparing the Pharmacokinetics and Tolerance of D-Gam® to Rhophylac® in Rh-D-negative Healthy Volunteers.CompletedNo Results AvailableHealthyBiological: D-Gam® (human anti-D immunoglobulin)|Biological: Rhophylac® (human anti-D immunoglobulin)https://ClinicalTrials.gov/show/NCT02246842
2428424284Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®)STARTRecruitingNo Results AvailableNeovascular Age-related Macular Degeneration of All SubtypesProcedure: Intravitreal injectionhttps://ClinicalTrials.gov/show/NCT02246829
2428524285A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001WithdrawnNo Results AvailableShort Bowel Syndrome|Short Gut Syndrome|SBS|Short GutDrug: 0.6 mL, MP-101 (10 mg/mL, Opium Tincture (OT)), USP (Deodorized)https://ClinicalTrials.gov/show/NCT02246816
2428624286The Assessment of Progression of Paroxysmal AF After CABGRecruitingNo Results AvailableParoxysmal Atrial Fibrillation, Coronary Artery DiseaseProcedure: CABG+Pulmonary vein isolation procedure|Procedure: Isolated CABGhttps://ClinicalTrials.gov/show/NCT02246803
2428724287Surgical Ablation of Long-standing Persistent AF During CABGRecruitingNo Results AvailableCoronary Artery DiseaseProcedure: Biatrial radiofrequency ablation and CABG|Procedure: Left atrial radiofrequency ablation and CABGhttps://ClinicalTrials.gov/show/NCT02246790
2428824288Alcon Ex-PRESSâ„¢ Glaucoma Filtration Device in Japanese PatientsRecruitingNo Results AvailableGlaucomaDevice: Ex-PRESSâ„¢ Glaucoma Filtration Device, Model P50PLhttps://ClinicalTrials.gov/show/NCT02246777
2428924289Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (Rocket-3)RecruitingNo Results AvailableOcular Hypertension.|GlaucomaDrug: AR-13324 Ophthalmic Solution, 0.02%, q.d.|Drug: AR-13324 Ophthalmic Solution, 0.02%, b.i.d.|Drug: Timolol maleate Ophthalmic Solution, 0.5%, b.i.d.https://ClinicalTrials.gov/show/NCT02246764
2429024290Case Series_Targeted Training for Trunk Control Cerebral PalsyRecruitingNo Results AvailableCerebral PalsyDevice: Targeted Training for trunk control using ORLAU standers (see description below)https://ClinicalTrials.gov/show/NCT02246751
2429124291Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer CohortsRecruitingNo Results AvailableUrothelial Carcinoma of the BladderOther: Blood Collectionhttps://ClinicalTrials.gov/show/NCT02246738
2429224292Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, RandRecruitingNo Results AvailableTumor in Upper Gastrointestinal Canal or Patients With Colorectal Cancer.Other: Contact with palliative care unit.https://ClinicalTrials.gov/show/NCT02246725
2429324293Influence of Diabetes on Tramadol PharmacokineticsCompletedNo Results AvailableNeuropathic Pain|Type 1 Diabetes Mellitus|Type 2 Diabetes MellitusDrug: Single oral dose of 100 mg racemic tramadol|Other: CYP2D6 phenotype|Other: CYP3A phenotype|Genetic: CYP2B6 genotypehttps://ClinicalTrials.gov/show/NCT02246712
2429424294Efficacy and Safety of a Fungal Chitosan on the Body Weight Reduction in Overweight and Obesity VolunteersCompletedNo Results AvailableOverweight and Obese Volunteers.Device: KiOnutrime®-Cs|Other: Placebohttps://ClinicalTrials.gov/show/NCT02246699
2429524295Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa PatientsRecruitingNo Results AvailableColitis, UlcerativeDrug: STW5-II (Iberogast N, BAY98-7410)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02246686
2429624296RDEA3170 and Febuxostat Combination Study in Gout SubjectsActive, not recruitingNo Results AvailableGoutDrug: RDEA3170 15 mg|Drug: RDEA3170 10 mg|Drug: RDEA3170 2.5|Drug: RDEA3170 5 mg|Drug: Febuxostat 40 mg|Drug: Febuxostat 80 mghttps://ClinicalTrials.gov/show/NCT02246673
2429724297RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)RecruitingNo Results AvailablePeripheral Arterial DiseaseDrug: Resveratrol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02246660
2429824298Biomarkers for Intestinal Permeability in Patients With ConstipationRecruitingNo Results AvailableIntestinal Diseases|Irritable Bowel Syndrome|ConstipationOther: saccharides|Procedure: esophagogastroduodenoscopy|Procedure: flexible sigmoidoscopyhttps://ClinicalTrials.gov/show/NCT02246647
2429924299Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)RecruitingNo Results AvailableColorectal Neoplasms|Neoplasm Metastases|Hepatic NeoplasmsOther: Diffusion Weighted MRI scanhttps://ClinicalTrials.gov/show/NCT02246634
2430024300A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast CancerRecruitingNo Results AvailableBreast CancerDrug: Abemaciclib|Drug: Anastrozole|Drug: Letrozole|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02246621

* Görseller ve İçerik tekif hakkına sahip olabilir